Biosimilars Licensing Agreement Updates - Life Sciences, Biotechnology & Nanotechnology : vimarsana.com

Earlier this week, Biocon Biologics Ltd. announced that it has entered into a strategic out-licensing agreement with Yoshindo Inc. to commercialize ustekinumab and denosumab biosimilars...

Related Keywords

Japan , Canada , Japanese , Biocon Biologics , Biocon Biologics Ltd , Yoshindo Inc , Biocon , Mondaq , Alvotech , Iocon , Iosimilars News , Enosumab , Stekinumab , Food , Rugs , Ealthcare , Ife Sciences , Life Sciences , Iotechnology Amp Nanotechnology , ,